TY - JOUR
T1 - Predatory organisms with untapped biosynthetic potential
T2 - Descriptions of novel corallococcus species C. aberystwythensis sp. nov., C. carmarthensis sp. nov., C. exercitus sp. nov., C. interemptor sp. nov., C. llansteffanensis sp. nov., C. praedator sp. nov., C. sicarius sp. nov., and C. terminator sp. nov.
AU - Livingstone, Paul G.
AU - Ingleby, Oliver
AU - Girdwood, Susan
AU - Cookson, Alan R.
AU - Morphew, Russell M.
AU - Whitworth, David E.
N1 - Publisher Copyright:
© 2020 American Society for Microbiology.
PY - 2020/1/7
Y1 - 2020/1/7
N2 - Corallococcus spp. are common soil-dwelling organisms which kill and consume prey microbes through the secretion of antimicrobial substances. Two species of Corallococcus have been described previously (Corallococcus coralloides and Corallococcus exiguus). A polyphasic approach, including biochemical analysis of fatty acid methyl esters, substrate utilization, and sugar assimilation assays, was taken to characterize eight Corallococcus species strains and the two type strains. The genomes of all strains, including that of C. exiguus DSM 14696T (newly reported here), shared an average nucleotide identity below 95% and digital DNA-DNA hybridization scores of less than 70%, indicating that they belong to distinct species. In addition, we characterized the prey range and antibiotic resistance profile of each strain, illustrating the diversity of antimicrobial activity and, thus, the potential for drug discovery within the Corallococcus genus. Each strain gave a distinct profile of properties, which together with their genomic differences supports the proposal of the eight candidate strains as novel species. The eight candidates are as follows: Corallococcus exercitus sp. nov. (AB043ATT DSM 108849 T NBRC 113887T), Corallococcus interemptor sp. nov. (AB047AT DSM 108843T NBRC 113888T), Corallococcus aberystwythensis sp. nov. (AB050AT DSM 108846T NBRC 114019T), Corallococcus praedator sp. nov. (CA031BT DSM 108841T NBRC 113889T), Corallococcus sicarius sp. nov. (CA040BT DSM 108850T NBRC 113890T), Corallococcus carmarthensis sp. nov. (CA043DT DSM 108842T NBRC 113891T), Corallococcus llansteffanensis sp. nov. (CA051BT DSM 108844T NBRC 114100T), and Corallococcus terminator sp. nov. (CA054AT DSM 108848T NBRC 113892T). Corallococcus is a genus of predators with broad prey ranges, whose genomes contain large numbers of gene clusters for secondary metabolite biosynthesis. The physiology and evolutionary heritage of eight Corallococcus species strains were characterized using a range of analyses and assays. Multiple metrics confirmed that each strain belonged to a novel species within the Corallococcus genus. The strains exhibited distinct patterns of drug resistance and predatory activity, which mirrored their possession of diverse sets of biosynthetic genes. The breadth of antimicrobial activities observed within the Corallococcus genus highlights their potential for drug discovery and suggests a previous underestimation of both their taxonomic diversity and biotechnological potential. Taxonomic assignment of environmental isolates to novel species allows us to begin to characterize the diversity and evolution of members of this bacterial genus with potential biotechnological importance, guiding future bioprospecting efforts for novel biologically active metabolites and antimicrobials.
AB - Corallococcus spp. are common soil-dwelling organisms which kill and consume prey microbes through the secretion of antimicrobial substances. Two species of Corallococcus have been described previously (Corallococcus coralloides and Corallococcus exiguus). A polyphasic approach, including biochemical analysis of fatty acid methyl esters, substrate utilization, and sugar assimilation assays, was taken to characterize eight Corallococcus species strains and the two type strains. The genomes of all strains, including that of C. exiguus DSM 14696T (newly reported here), shared an average nucleotide identity below 95% and digital DNA-DNA hybridization scores of less than 70%, indicating that they belong to distinct species. In addition, we characterized the prey range and antibiotic resistance profile of each strain, illustrating the diversity of antimicrobial activity and, thus, the potential for drug discovery within the Corallococcus genus. Each strain gave a distinct profile of properties, which together with their genomic differences supports the proposal of the eight candidate strains as novel species. The eight candidates are as follows: Corallococcus exercitus sp. nov. (AB043ATT DSM 108849 T NBRC 113887T), Corallococcus interemptor sp. nov. (AB047AT DSM 108843T NBRC 113888T), Corallococcus aberystwythensis sp. nov. (AB050AT DSM 108846T NBRC 114019T), Corallococcus praedator sp. nov. (CA031BT DSM 108841T NBRC 113889T), Corallococcus sicarius sp. nov. (CA040BT DSM 108850T NBRC 113890T), Corallococcus carmarthensis sp. nov. (CA043DT DSM 108842T NBRC 113891T), Corallococcus llansteffanensis sp. nov. (CA051BT DSM 108844T NBRC 114100T), and Corallococcus terminator sp. nov. (CA054AT DSM 108848T NBRC 113892T). Corallococcus is a genus of predators with broad prey ranges, whose genomes contain large numbers of gene clusters for secondary metabolite biosynthesis. The physiology and evolutionary heritage of eight Corallococcus species strains were characterized using a range of analyses and assays. Multiple metrics confirmed that each strain belonged to a novel species within the Corallococcus genus. The strains exhibited distinct patterns of drug resistance and predatory activity, which mirrored their possession of diverse sets of biosynthetic genes. The breadth of antimicrobial activities observed within the Corallococcus genus highlights their potential for drug discovery and suggests a previous underestimation of both their taxonomic diversity and biotechnological potential. Taxonomic assignment of environmental isolates to novel species allows us to begin to characterize the diversity and evolution of members of this bacterial genus with potential biotechnological importance, guiding future bioprospecting efforts for novel biologically active metabolites and antimicrobials.
KW - Comparative genomics
KW - Myxobacteria
KW - Predation
KW - Predator
KW - Prey
UR - http://www.scopus.com/inward/record.url?scp=85077667131&partnerID=8YFLogxK
U2 - 10.1128/AEM.01931-19
DO - 10.1128/AEM.01931-19
M3 - Article
C2 - 31676482
AN - SCOPUS:85077667131
SN - 0099-2240
VL - 86
JO - Applied and Environmental Microbiology
JF - Applied and Environmental Microbiology
IS - 2
M1 - e01931-19
ER -